Global Technologies for Diabetes Management Forecasts, Players, Opportunities Report 2017-2027 -

DUBLIN--()--The "Technologies for Diabetes Management 2017-2027: Forecasts, Players, Opportunities" report has been added to's offering.

This report covers mature, growing and emerging fields in diabetes technology, researched through primary interviews with companies, physicians and diabetic individuals to establish how the technological roadmap for diabetes management will develop over the next decade.

The report examines diabetes technologies across seven key areas:

Sensors for glucose monitoring - The established blood glucose market manufactures over 20 billion test strips annually, however, as is discussed here, several factors are restraining the profitability of the industry and driving technological changes.

Beyond blood glucose measurements - Glucose exists in biological fluids other than blood, continuous glucose monitors and wearable devices are gaining traction and seeing large uptake by consumers.

Sensors for Ketone monitoring - When blood glucose levels are too high, acidic ketone bodies, the by-product of improper metabolism build up in the blood stream, leading to potentially life threatening complications. The range of available biosensors to measure and quantify ketone levels are reviewed.

Smart insulin pens - Start-ups backed by large pharmaceutical companies are adding sensors and connectivity to insulin pens to unlock a range of analytical tools. Several leading start-ups an companies are profiled and their products discussed.

Insulin pumps: towards an artificial pancreas - Compared to insulin pens, insulin pumps offer a more controlled rate of hormone delivery. Discussed is the progress whereby combining pump technologies with continuous glucose monitoring platforms is leading to the development of an artificial pancreas device, offering real-time sensor automated insulin delivery in response to changing glucose levels.

Sensors for side effects - Covering the diverse utilisation of innovative sensor technologies across novel aspects diabetes care, including; sensors in wearable devices, the ability to monitor other end points such as diabetic neuropathy as well as assessing ulcer development in diabetic patients.

Sensors for early diagnosis - Discussing the use of emerging technologies to aid the early detection of diabetes, thereby preventing long hospital stays and other complications.

The report contains 10 year forecasts across all relevant market segments, detailing revenue predictions, and volumes across multiple sensing technologies.

The analyst has identified and profiled key players to build a comprehensive picture of the diabetes technology industry. Significant stakeholders have been identified and profiled through primary research and interviews to understand the technology roadmap of diabetes care and to give an insightful, contextual and timely analysis of the industry now and in the future, identifying factors crucial for the triumph of a company in this ever-growing field.

Key Topics Covered:

1. Executive Summary

2. Introduction To Diabetes

3. Market Forecasts

4. Sensors For Glucose Monitoring

5. Beyond Blood Glucose Measurements

6. Sensors For Ketone Monitoring

7. Sensors For Insulin Pens

8. Insulin Pumps: Towards An Artificial Pancreas

9. Sensors For Side Effects

10. Sensors For Early Diagnosis

11. Regulation And Availability Of Diabetes Medical Devices

12. Company Profiles

  • Companion Medical
  • Dexcom
  • Dropsens
  • Emperra
  • GSI
  • GSK Medical
  • Glysens
  • Google-Verily
  • Medtronic
  • Nanoflex
  • PKVitality
  • Sensoria

For more information about this report visit

Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrinology

Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrinology